Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- What's wrong
- Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
- Products
-
- Abirtega (abiraterone acetate) USP
- Company
- Hikma Pharmaceuticals USA INC.
- Where it was sold
-
Nationwide within the United States
- Units affected
- 2136 bottles
- Status
- Ongoing
Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.